Cytophage Technologies (TSXV:CYTO) Accounts Payable & Accrued Expense : C$0.38 Mil (As of Sep. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Cytophage Technologies Accounts Payable & Accrued Expense?

Cytophage Technologies's quarterly accounts payable & accrued expense declined from Mar. 2024 (C$0.53 Mil) to Jun. 2024 (C$0.41 Mil) and declined from Jun. 2024 (C$0.41 Mil) to Sep. 2024 (C$0.38 Mil).

Cytophage Technologies's annual accounts payable & accrued expense increased from Dec. 2021 (C$0.03 Mil) to Dec. 2022 (C$0.13 Mil) but then declined from Dec. 2022 (C$0.13 Mil) to Dec. 2023 (C$0.05 Mil).

Cytophage Technologies Accounts Payable & Accrued Expense Historical Data

The historical data trend for Cytophage Technologies's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cytophage Technologies Accounts Payable & Accrued Expense Chart

Cytophage Technologies Annual Data

Trend

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

0.03

0.13

0.05

Cytophage Technologies Quarterly Data
	Dec21	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial					0.20	0.05	0.53	0.41	0.38

Cytophage Technologies Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Cytophage Technologies Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cytophage Technologies Ltd (TSXV:CYTO) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

26 Henlow Bay, Winnipeg, MB, CAN, R3Y 1G4

Website

https://www.cytophage.com

Cytophage Technologies Ltd is a Canadian biotechnology company that uses molecular genetic techniques and synthetic biology to create effective bacteriophages to address bacterial challenges affecting animal health, human health, and food security. Bacteriophages are viruses that have evolved to specifically target and destroy strictly bacterial cells and are safe for humans, animals, and plants. To combat dangerous bacteria company generates phages to address specific bacterial infections, including strains resistant to antibiotics. It has also developed a 'phage-display' methodology to develop vaccine-like products using bacteriophages for a number of potential applications in human and animal health.